Inventor profile of:

Sonja Theisinger

City:

Mannheim

Country:

Germany

Published Applications:

31

Last publication date:

2025-11-13

Top Assignees for applications by Sonja Theisinger

The entities that hold a legal rights for patent applications filed by inventor Theisinger Sonja:

Recent patent applications by Theisinger Sonja

Sonja Theisinger from Mannheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-13
US20250345276A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#2 | 2024-10-24
US20240350425A1
Human necessities

COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES

#3 | 2023-10-19
US20230330056A1
Human necessities

SEMIFLUORINATED ALKANE COMPOSITIONS

#4 | 2023-05-04
US20230139672A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#5 | 2022-07-14
US20220218828A1
Human necessities

TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES

#6 | 2021-04-08
US20210100904A1
Human necessities

Topical pharmaceutical composition based on semifluorinated alkanes

#7 | 2020-11-19
US20200360285A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#8 | 2020-08-06
US20200246463A1
Human necessities

Semifluorinated alkane compositions

#9 | 2020-07-02
US20200206241A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#10 | 2020-06-18
US20200188318A1
Human necessities

Compositions comprising mixtures of semifluorinated alkanes

#11 | 2019-08-08
US20190240234A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#12 | 2019-07-25
US20190224123A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#13 | 2018-11-15
US20180326066A1
Human necessities

Semifluorinated alkane compositions

#14 | 2018-10-25
US20180303849A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#15 | 2018-08-09
US20180221485A1
Human necessities

Liquid pharmaceutical composition for the delivery of active ingredients

#16 | 2018-03-15
US20180071229A1
Human necessities

Compositions comprising mixtures of semifluorinated alkanes

#17 | 2018-01-25
US20180021434A1
Human necessities

Topical pharmaceutical composition based on semifluorinated alkanes

#18 | 2018-01-11
US20180008710A1
Human necessities

Liquid pharmaceutical composition for the delivery of active ingredients

#19 | 2017-08-03
US20170216204A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#20 | 2017-05-25
US20170143832A1
Human necessities

Semifluorinated alkane compositions

#21 | 2015-08-13
US20150224064A1
Human necessities

Methods of treating ocular disorders using semifluorinated alkanes

#22 | 2014-12-18
US20140369993A1
Human necessities

Stabilised protein compositions based on semifluorinated alkanes

#23 | 2014-08-07
US20140221485A1
Chemistry; metallurgy

LIPOPHILIC DOPAMINE DERIVATIVES AND THEIR USE

#24 | 2014-05-22
US20140140942A1
Human necessities

Pharmaceutical composition for administration to nails

#25 | 2014-04-10
US20140100180A1
Human necessities

Topical pharmaceutical composition based on semifluorinated alkanes

#26 | 2014-01-02
US20140004197A1
Human necessities

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

#27 | 2013-10-10
US20130266652A1
Human necessities

Liquid pharmaceutical composition for the delivery of active ingredients

#28 | 2013-06-06
US20130142866A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVED ORGAN TRANSPLANT PRESERVATION AND ACCEPTANCE

#29 | 2013-02-21
US20130046014A1
Human necessities

Pharmaceutical composition for treatment of increased intraocular pressure

#30 | 2012-09-27
US20120244177A1
Human necessities

Pharmaceutical composition for treatment of dry eye syndrome

#31 | 2012-09-20
US20120238639A1
Human necessities

Pharmaceutical composition comprising propofol

InventorID:

274083 ⎘